ARTClinica offers technology solutions for trials

Thursday, March 24, 2011 12:17 PM

N.J.-based ARTClinica has introduced its same-name software solution, a customizable solution combining Electronic Data Capture (EDC), Clinical Trial Management (CTMS) with optional Interactive Voice/Web Response Software (IVRS/ IWRS) into a single integrated system.

ARTClinica aims to support biopharma companies with a lightweight integrated eClinical solution, CROs managing studies, independent clinics, pharmaceutical companies collaborating on a study and imaging labs.

Sina Adibi, general manager of ARTClinica, said, "ARTClinica offers a new approach in technology applications integration for use in clinical trials. By building tight integration between IVR/ IWR and EDC, we have effectively combined EDC-IVR capabilities in such a way that IVR is just another interface to our robust web-based EDC. Our role-based workflow environment allows for speedy study protocol configuration and site setup, easy electronic case report form composition (eCRFs), enabling study managers to effectively collect data and manage trials securely."

ARTClinica's development, validation and support team includes a 24/7 help desk with experience in developing study management tools. An IT project manager is also assigned to coordinate all setup new accounts as well as ongoing systems activities.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs